An overview of antibody–drug conjugates in oncological practice

Antibody–drug conjugates (ADCs) are designed to manipulate the toxic efficacy of specific chemotherapeutic compounds, employing the high affinity of antibody-mediated delivery so as to drive them selectively to target cancer cells. These immunoconjugates encompass the general tendency towards precis...

Descripción completa

Detalles Bibliográficos
Autores principales: Theocharopoulos, Charalampos, Lialios, Panagiotis-Petros, Gogas, Helen, Ziogas, Dimitrios C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543133/
https://www.ncbi.nlm.nih.gov/pubmed/33088347
http://dx.doi.org/10.1177/1758835920962997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543133/
https://www.ncbi.nlm.nih.gov/pubmed/33088347
http://dx.doi.org/10.1177/1758835920962997

Ejemplares similares